Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia

NCT04013555 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT04013555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04013555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 1/2
Overall status
Completed
Start date
January 20, 2020
Completion date
August 14, 2024
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, schizophreniform disorder